Uganda - Ingliż - National Drug Authority

guilin pharmaceuticals co.ltd - artesunate+amodiaquine - oral solid ordinary tablets - 50mg+135mg

Kanada - Ingliż - Health Canada

ranbaxy pharmaceuticals canada inc. - quinapril (quinapril hydrochloride) - tablet - 20mg - quinapril (quinapril hydrochloride) 20mg - angiotensin-converting enzyme inhibitors

Kanada - Ingliż - Health Canada

ranbaxy pharmaceuticals canada inc. - quinapril (quinapril hydrochloride) - tablet - 40mg - quinapril (quinapril hydrochloride) 40mg - angiotensin-converting enzyme inhibitors

Stati Uniti - Ingliż - NLM (National Library of Medicine)

clinical solutions wholesale - ondansetron (unii: 4af302esos) (ondansetron - unii:4af302esos) - ondansetron 4 mg

Stati Uniti - Ingliż - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - ondansetron (unii: 4af302esos) (ondansetron - unii:4af302esos) - ondansetron 8 mg

Stati Uniti - Ingliż - NLM (National Library of Medicine)

proficient rx lp - ondansetron (unii: 4af302esos) (ondansetron - unii:4af302esos) - 1. prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin ≥ 50 mg/m2 . 2. prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. 3. prevention of nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen. 4. prevention of postoperative nausea and/or vomiting. as with other antiemetics, routine prophylaxis is not recommended for patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. in patients where nausea and/or vomiting must be avoided postoperatively, ondansetron hydrochloride tablets, ondansetron orally disintegrating tablets, and ondansetron hydrochloride oral solution are recommended even where the incidence of postoperative nausea and/or vomiting is low. the concomitant use of apomorphine with ondansetron is contraindic

Unjoni Ewropea - Ingliż - EMA (European Medicines Agency)

advicenne s.a. - potassium citrate monohydrated, potassium hydrogen carbonate - acidosis, renal tubular - mineral supplements - sibnayal is indicated for the treatment of distal renal tubular acidosis (drta) in adults, adolescents and children aged one year and older.

Unjoni Ewropea - Ingliż - EMA (European Medicines Agency)

substipharm - raloxifene hydrochloride - osteoporosis, postmenopausal - sex hormones and modulators of the genital system, - evista is indicated for the treatment and prevention of osteoporosis in post-menopausal women. a significant reduction in the incidence of vertebral, but not hip fractures has been demonstrated. when determining the choice of evista or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefits.

Unjoni Ewropea - Ingliż - EMA (European Medicines Agency)

biotest pharma gmbh - human hepatitis b immunoglobulin - immunization, passive; hepatitis b; liver transplantation - immune sera and immunoglobulins, - prevention of hepatitis b virus (hbv) re-infection in hbsag and hbv-dna negative adult patients at least one week after liver transplantation for hepatitis b induced liver failure. hbv-dna negative status should be confirmed within the last 3 months prior to olt. patients should be hbsag negative before treatment start. the concomitant use of adequate virostatic agents should be considered as standard of hepatitis b re-infection prophylaxis.,

Kanada - Ingliż - Health Canada

bgp pharma ulc - tolterodine tartrate - tablet - 1mg - tolterodine tartrate 1mg - antimuscarinics